Marvel Medilinks Private Limited
About Marvel Medilinks Private Limited
Data last updated:
Marvel Medilinks Private Limited is a private limited company based in Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 June 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231PB1993PTC013449. Its GSTIN is 03AABCM1048E1Z5 (Punjab).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹39.99 Lakh. It is led by directors Rina Blaggan and Pooja Gandhi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Amritsar, Punjab, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.48 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹68,556 (net margin 0.5%) and EBITDA of ₹16.08 Lakh (EBITDA margin 10.8%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 6% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.3 Cr and satisfied charges of ₹7.08 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressAmritsar, Punjab, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Marvel Medilinks Private Limited
The main business activity of Marvel Medilinks is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Marvel Medilinks Private Limited FY 2025 filings available
Marvel Medilinks Private Limited reported revenue of ₹1.48 Cr (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Marvel Medilinks Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 4% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Marvel Medilinks Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.08 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹68,556 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Marvel Medilinks Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Marvel Medilinks are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Marvel Medilinks Private Limited
Marvel Medilinks Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lahar Chemicals Private Limited | ₹1.5 Cr (FY 2024) | •••• | •••• | 717.0% | •••• | New Delhi, Delhi, India |
| Micropan Pharmachem Private Limited | ₹1.49 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Navi Mumbai, Maharashtra, India |
| Unihelix Biotech Private Limited | ₹1.49 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Kolkata, West Bengal, India |
| Chemixl Intermediates Private Limited | ₹1.49 Cr (FY 2025) | •••• | •••• | -41.0% | •••• | Umargam, Gujarat, India |
| Native Drugs Private Limited | ₹1.49 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Amritsar, Punjab, India |
| Marvel Medilinks Private Limited this company | ₹1.48 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Punjab, India |
| Harisons Pharmaceuticals Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Chandigarh, India |
| Florian Lifescience Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Patna, Bihar, India |
| Peptas Pharma Private Limited | ₹1.48 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Hyderabad, Telangana, India |
| Curezip Pharma Private Limited | ₹1.47 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Nawada, Bihar, India |
| Bestcare Lifesciences Private Limited | ₹1.47 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Marvel Medilinks by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Marvel Medilinks Private Limited
Marvel Medilinks Private Limited is audited by DAVINDER K MALHOTRA & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DAVINDER K MALHOTRA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Marvel Medilinks Private Limited
Marvel Medilinks has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rina Blaggan Also directs: Marvel Natural Resources Private Limited | Director | 18 Jun 1993 | 33 Years 3 Months | Current |
| Pooja Gandhi Also directs: Marvel Natural Resources Private Limited | Director | 31 Aug 2015 | 11 Years 1 Months | Current |
Ownership and Shareholding of Marvel Medilinks Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Marvel Medilinks Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2013 | Corporation Bank | ₹1 Cr | Open |
| 18 Jun 1996 | Corporation Bank | ₹30 Lakh | Open |
| 05 Oct 2009 | Corporation Bank Ltd. | ₹6.64 Cr | Satisfied |
| 19 May 2004 | Corporation Bank | ₹28 Lakh | Satisfied |
| 09 Feb 1995 | Corporation Bank | ₹8 Lakh | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Marvel Medilinks Private Limited
Marvel Medilinks Private Limited has a workforce of 9 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Marvel Medilinks Private Limited
Marvel Medilinks Private Limited has 5 board changes on record since 1993: 2 appointments and 3 cessations. The latest: Subhash Malhotra ceased to be Director on 15 Jun 2019.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Marvel Medilinks Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Marvel Medilinks Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Marvel Medilinks Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Marvel Medilinks Private Limited
Marvel Medilinks has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AABCM1048E1Z5 | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Marvel Medilinks Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Marvel Medilinks Private Limited
Marvel Medilinks is an active private limited company based in Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 June 1993 (33+ years old) and is registered under CIN U24231PB1993PTC013449.
Marvel Medilinks reported revenue of ₹1.48 Cr for FY 2024 (up 4% YoY).
Marvel Medilinks has 2 current directors:
- Rina Blaggan - Director
- Pooja Gandhi - Director
Marvel Medilinks reported a net profit of ₹68,556 (net margin 0.5%) and EBITDA of ₹16.08 Lakh (EBITDA margin 10.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Marvel Medilinks is 16% over three years and 6% over five years. In the latest year (FY 2024) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Marvel Medilinks is 03AABCM1048E1Z5, registered in Punjab.
The CIN (Corporate Identification Number) of Marvel Medilinks is U24231PB1993PTC013449. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Marvel Medilinks was incorporated on 18 June 1993, making it 33+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Marvel Medilinks by revenue are Lahar Chemicals Private Limited, Micropan Pharmachem Private Limited, Unihelix Biotech Private Limited, Chemixl Intermediates Private Limited, Native Drugs Private Limited and 5 more, all in the Pharma industry (Formulations).
Subhash Malhotra ceased to be Director on 15 Jun 2019. Pooja Gandhi was appointed as Director on 31 Aug 2015. Pardeep Blaggan ceased to be Director on 24 Aug 2015. Marvel Medilinks has 5 board changes on record in total.
The registered office of Marvel Medilinks is at Amritsar, Punjab, India.